ZA91604B - Aromatase inhibitors - Google Patents

Aromatase inhibitors

Info

Publication number
ZA91604B
ZA91604B ZA91604A ZA91604A ZA91604B ZA 91604 B ZA91604 B ZA 91604B ZA 91604 A ZA91604 A ZA 91604A ZA 91604 A ZA91604 A ZA 91604A ZA 91604 B ZA91604 B ZA 91604B
Authority
ZA
South Africa
Prior art keywords
aromatase inhibitors
aromatase
inhibitors
Prior art date
Application number
ZA91604A
Other languages
English (en)
Inventor
Fernand Labrie
Labrie Fernand
Yves Merand
Merand Yves
Original Assignee
Endorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc filed Critical Endorecherche Inc
Publication of ZA91604B publication Critical patent/ZA91604B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA91604A 1990-02-08 1991-01-28 Aromatase inhibitors ZA91604B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/477,024 US5227375A (en) 1990-02-08 1990-02-08 Aromatase inhibitors

Publications (1)

Publication Number Publication Date
ZA91604B true ZA91604B (en) 1992-09-30

Family

ID=23894189

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91604A ZA91604B (en) 1990-02-08 1991-01-28 Aromatase inhibitors

Country Status (10)

Country Link
US (1) US5227375A (fr)
AU (1) AU7150991A (fr)
GR (1) GR910100067A (fr)
IE (1) IE65269B1 (fr)
IL (1) IL97122A (fr)
MY (1) MY105479A (fr)
NZ (1) NZ236966A (fr)
TW (1) TW221418B (fr)
WO (1) WO1991012206A2 (fr)
ZA (1) ZA91604B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0180008B1 (ko) * 1991-03-28 1999-04-01 야마구찌 다까시 신규 옥사-또는 아자스테로이드 유체
ATE179179T1 (de) * 1992-09-30 1999-05-15 Teikoku Hormone Mfg Co Ltd 7-substituierte oxa-steroid verbindung
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
AU8779898A (en) * 1997-08-11 1999-03-01 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
BR9908592A (pt) 1998-03-11 2001-04-24 Endorech Inc Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit
WO2001014406A1 (fr) * 1999-08-23 2001-03-01 Chugai Seiyaku Kabushiki Kaisha Agents anti-androgènes
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
CA2480151A1 (fr) * 2002-03-22 2003-10-09 Pharmacia Corporation Spirolactonisation c-17 et oxydation 6,7 de steroides
MXPA05004024A (es) * 2002-11-07 2005-06-08 Pharmacia & Upjohn Co Llc Procedimientos para preparar esteroides c-7 sustituidos.
US8183401B2 (en) * 2004-01-16 2012-05-22 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
AU2011256088B2 (en) * 2010-05-20 2015-03-26 University Of Saskatchewan Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
WO2014169395A1 (fr) 2013-04-19 2014-10-23 University Of Saskatchewan Dispositif intravaginal libérant un inhibiteur de l'aromatase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125069C (fr) * 1963-12-24
US3380886A (en) * 1965-04-07 1968-04-30 Upjohn Co 7alpha-methyl-3beta-hydroxy-5-androstenes
US3591607A (en) * 1966-04-19 1971-07-06 Hoffmann La Roche Retrosteroid a-ring formation
US3766213A (en) * 1966-04-19 1973-10-16 Hoffmann La Roche Retrosteroid a ring formation
US3485828A (en) * 1967-04-10 1969-12-23 Syntex Corp 6,7-ethylene and 6,7-substituted ethylene derivatives of the pregnane series
US3952018A (en) * 1972-01-14 1976-04-20 Hoffmann-La Roche Inc. 15-Oxasteroids
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
DE3121153A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"
US4451404A (en) * 1983-02-09 1984-05-29 The Upjohn Company 16β-Methyl steroid process
US4596796A (en) * 1983-09-12 1986-06-24 Sumitomo Chemical Company, Limited Dithiolphosphoric acid ester as a soil pesticide
DE3612632A1 (de) * 1986-04-11 1987-10-22 Schering Ag Verfahren zur herstellung von 7(alpha)-propylsteroiden
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives

Also Published As

Publication number Publication date
WO1991012206A2 (fr) 1991-08-22
IE910263A1 (en) 1991-08-14
IL97122A0 (en) 1992-05-25
WO1991012206A3 (fr) 1991-11-28
GR910100067A (el) 1992-06-30
AU7150991A (en) 1991-09-03
US5227375A (en) 1993-07-13
MY105479A (en) 1994-10-31
IE65269B1 (en) 1995-10-18
IL97122A (en) 1996-06-18
TW221418B (fr) 1994-03-01
NZ236966A (en) 1993-11-25

Similar Documents

Publication Publication Date Title
GB9019558D0 (en) Enzyme inhibitors
EP0474540A3 (en) Scale inhibitor for calcium-type scale
GB2244487B (en) Azole derivatives
ZA91604B (en) Aromatase inhibitors
ZA918716B (en) 1-(2-arylethyl)-pyrrolidines
HU9503783D0 (en) Squvalen syntetase inhibitors
HU906389D0 (en) New alpha-glycosidase inhibitors
IL102216A0 (en) Selective aromatase inhibiting 4(5)-imidazoles
GB9223390D0 (en) Anti-hpa1 testing
GB9220772D0 (en) Novel triazoles
ZA902479B (en) Aromatase inhibiting 4(5)-imidazoles
GB2271056B (en) An eyebath
GB9026251D0 (en) Netalloproteinase inhibitors
HU912393D0 (en) Glass-cup for drink-automats
IE881856L (en) Aromatase inhibitors
GB9007750D0 (en) Enzyme inhibitors
ZA914716B (en) Ace inhibitors
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
HU9904088D0 (en) Dual action inhibitors
ZA912264B (en) 5-lipoxygenase inhibitors
GB9217364D0 (en) Heterocyclic agents
GB9214448D0 (en) Heterocyclic agents
GB9118480D0 (en) Steroid suphatase inhibitors
GB8330001D0 (en) Aromatase inhibitors
GB9222948D0 (en) Geolographic stress inhibitor